External beam radiation therapy as an alternative to brachytherapy for locally advanced cervical cancer
https://doi.org/10.21294/1814-4861-2025-24-2-162-168
Abstract
The purpose of the study was to analyze and summarize the available literature data on the potential value of radiation therapy for locally advanced cervical cancer and to present alternative treatment options when conventional treatment is not feasible. Material and Methods. A literature search was conducted using PubMed and Cochrane Library databases as well as databases of clinical materials from the Ministry of Health of the Russian Federation, ASCO (American Society of Clinical Oncology), and National Comprehensive Cancer Network (NCCN). Literature sources and publications from 2004 to 2021 were included into the review. Results. The review outlines the basic principles of classical treatment of locally advanced cervical cancer (external beam radiation therapy followed by brachytherapy boost). Alternative treatment options for patients not eligible for brachytherapy have been shown. Methods of using stereotactic treatment as an alternative to brachytherapy have been described. The results of researches who applied a new treatment method, namely, two-stage stereotactic body radiation therapy for patients with locally advanced cervical cancer have been demonstrated. Conclusion. The use of modern devices for radiation therapy, such as the linear electron accelerator and modern planning stations for medical physicists, may make it possible to use a new option in the treatment of patients with locally advanced cervical cancer – the use of stereotactic boost. This issue is still controversial and requires further study.
About the Authors
Zh. A. Startseva
Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
Russian Federation
Zhanna A. Startseva, MD, DSc, Professor of the Russian Academy of Sciences, Head of the Radiotherapy Department
5, Kooperativny St., Tomsk, 634009
P. A. Lushnikova
Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences ; Tomsk Regional Oncology Center
Russian Federation
Russian Federation
Polina A. Lushnikova, MD, Oncologist, Radiotherapy Department; Radiotherapist, Radiotherapy Department
5, Kooperativny St., Tomsk, 634009
115, Lenin Ave., Tomsk, 634050
E. S. Sukhikh
Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences ; National Research Tomsk Polytechnic University
Russian Federation
Russian Federation
Evgeniya S. Sukhikh, PhD, Member of the Association of Medical Physicists of Russia (AMPR); Researcher; Senior Lecturer
5, Kooperativny St., Tomsk, 634009
30, Lenin Ave., Tomsk, 634050
References
1. Sagae S., Toita T., Matsuura M., Saito M., Matsuda T., Sato N., Shimizu A., Endo T., Fujii M., Gaffney D.K., Small W. Jr. Improvement in radiation techniques for locally advanced cervical cancer during the last two decades. Int J Gynecol Cancer. 2023; 33(8): 1295–303. doi: 10.1136/ijgc-2022-004230.
2. Pötter R., Tanderup K., Kirisits C., de Leeuw A., Kirchheiner K., Nout R., Tan L.T., Haie-Meder C., Mahantshetty U., Segedin B., Hoskin P., Bruheim K., Rai B., Huang F., Van Limbergen E., Schmid M., Nesvacil N., Sturdza A., Fokdal L., Jensen N.B.K., Georg D., Assenholt M., Seppenwoolde Y., Nomden C., Fortin I., Chopra S., van der Heide U., Rumpold T., Lindegaard J.C., Jürgenliemk-Schulz I.; EMBRACE Collaborative Group. The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol. 2018; 9: 48–60. doi: 10.1016/j.ctro.2018.01.001.
3. Cervical cancer: Clinical recommendations of the Ministry of Health of the Russian Federation. 2020. (in Russian). [Internet]. [cited 01.05.2025]. URL: https://cr.minzdrav.gov.ru/previewcr/554_3.
4. Klopp A.H., Yeung A.R., Deshmukh S., Gil K.M., Wenzel L., Westin S.N., Gifford K., Gaffney D.K., Small W. Jr, Thompson S., Doncals D.E., Cantuaria G.H.C., Yaremko B.P., Chang A., Kundapur V., Mohan D.S., Haas M.L., Kim Y.B., Ferguson C.L., Pugh S.L., Kachnic L.A., Bruner D.W. Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203. J Clin Oncol. 2018; 36(24): 2538–44. doi: 10.1200/JCO.2017.77.4273. Erratum in: J Clin Oncol. 2019; 37(9): 761. doi: 10.1200/JCO.19.00369. Erratum in: J Clin Oncol. 2020; 38(10): 1118. doi: 10.1200/JCO.20.00346.
5. Sukhikh E.S., Sukhikh L.G., Vertinsky A.V., Baulin A.A., Tatarchenko M.A., Sutygina Ya.N. Dosimetric planning and quality control of high dose rate brachytherapy. Tomsk, 2020. 115 p. (in Russian). ISBN 978-5-4387-0964-0.
6. Abu-Rustum N.R., Yashar C.M., Arend R., Barber E., Bradley K., Brooks R., Campos S.M., Chino J., Chon H.S., Crispens M.A., Damast S., Fisher C.M., Frederick P., Gaffney D.K., Gaillard S., Giuntoli R. II, Glaser S., Holmes J., Howitt B.E., Kendra K., Lea J., Lee N., MantiaSmaldone G., Mariani A., Mutch D., Nagel C., Nekhlyudov L., Podoll M., Rodabaugh K., Salani R., Schorge J., Siedel J., Sisodia R., Soliman P., Ueda S., Urban R., Wethington S.L., Wyse E., Zanotti K., McMillian N., Espinosa S. Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024; 22(2): 117–35. doi: 10.6004/jnccn.2024.0013.
7. Lertsanguansinchai P., Lertbutsayanukul C., Shotelersuk K., Khorprasert C., Rojpornpradit P., Chottetanaprasith T., Srisuthep A., Suriyapee S., Jumpangern C., Tresukosol D., Charoonsantikul C. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma. Int J Radiat Oncol Biol Phys. 2004; 59(5): 1424–31. doi: 10.1016/j.ijrobp.2004.01.034.
8. Scott A.A., Yarney J., Vanderpuye V., Akoto Aidoo C., Agyeman M., Boateng S.N., Sasu E., Anarfi K., Obeng-Mensah T. Outcomes of patients with cervical cancer treated with low- or high-dose rate brachytherapy after concurrent chemoradiation. Int J Gynecol Cancer. 2021; 31(5): 670–78. doi: 10.1136/ijgc-2020-002120.
9. Han K., Colson-Fearon D., Liu Z.A., Viswanathan A.N. Updated Trends in the Utilization of Brachytherapy in Cervical Cancer in the United States: A Surveillance, Epidemiology, and End-Results Study. Int J Radiat Oncol Biol Phys. 2024; 119(1): 143–53. doi: 10.1016/j.ijrobp.2023.11.007.
10. Chuang L.T., Temin S., Camacho R., Dueñas-Gonzalez A., Feldman S., Gultekin M., Gupta V., Horton S., Jacob G., Kidd E.A., Lishimpi K., Nakisige C., Nam J.H., Ngan H.Y.S., Small W., Thomas G., Berek J.S. Management and Care of Women With Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline. J Glob Oncol. 2016; 2(5): 311–40. doi: 10.1200/JGO.2016.003954.
11. Mahmoud O., Kilic S., Khan A.J., Beriwal S., Small W. Jr. External beam techniques to boost cervical cancer when brachytherapy is not an option-theories and applications. Ann Transl Med. 2017; 5(10): 207. doi: 10.21037/atm.2017.03.102.
12. Fokdal L., Sturdza A., Mazeron R., Haie-Meder C., Tan L.T., Gillham C., Šegedin B., Jürgenliemk-Schultz I., Kirisits C., Hoskin P., Pötter R., Lindegaard J.C., Tanderup K. Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study. Radiother Oncol. 2016; 120(3): 434–40. doi: 10.1016/j.radonc.2016.03.020.
13. Haque W., Butler E.B., Teh B.S. Stereotactic body radiation therapy for prostate cancer-a review. Chin Clin Oncol. 2017; 6(s2). doi: 10.21037/cco.2017.06.05.
14. Bisht S.S., Kataria T., Shishak S., Gupta D., Kaliyaperumal V., Wadhwa J., Suryavanshi M., Banerjee S., Narang K., Goyal S., Rathi D., Mayank M., Selvaraj R., Khandelwal A. Total ablative stereotactic body radiotherapy to primary and oligometastatic renal cell carcinoma in medically inoperable cases: An institutional analysis. Indian J Urol. 2023; 39(4): 303–10. doi: 10.4103/iju.iju_104_23.
15. Fakiris A.J., McGarry R.C., Yiannoutsos C.T., Papiez L., Williams M., Henderson M.A., Timmerman R. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys. 2009; 75(3): 677–82. doi: 10.1016/j.ijrobp.2008.11.042.
16. Guerrero M., Li X.A., Ma L., Linder J., Deyoung C., Erickson B. Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations. Int J Radiat Oncol Biol Phys. 2005; 62(3): 933–39. doi: 10.1016/j.ijrobp.2004.11.040.
17. Tanderup K., Fokdal L.U., Sturdza A., Haie-Meder C., Mazeron R., van Limbergen E., Jürgenliemk-Schulz I., Petric P., Hoskin P., Dörr W., Bentzen S.M., Kirisits C., Lindegaard J.C., Pötter R. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer. Radiother Oncol. 2016; 120(3): 441–46. doi: 10.1016/j.radonc.2016.05.014. Erratum in: Radiother Oncol. 2017; 123(1): 169. doi: 10.1016/j.radonc.2017.01.022.
18. Kim H., Kim Y.S., Joo J.H., Eom K.Y., Park W., Kim J.H., Lee J.H., Kim Y.S., Lee S.H., Ahn K., Kim Y.B., Lee M.Y., Chang S.K. Tumor Boost Using External Beam Radiation in Cervical Cancer Patients Unable to Receive Intracavitary Brachytherapy: Outcome From a Multicenter Retrospective Study (Korean Radiation Oncology Group 1419). Int J Gynecol Cancer. 2018; 28(2): 371–78. doi: 10.1097/IGC.0000000000001155.
19. Facondo G., Vullo G., De Sanctis V., Valeriani M., Ascolese A.M., Massaro M., Anzellini D., Osti M.F. Stereotactic Body Radiation Therapy Boost in Patients With Cervical Cancer Ineligible for Brachytherapy. Cancer Diagn Progn. 2021; 1(2): 53–60. doi: 10.21873/cdp.10008.
20. Schwartz L.H., Litière S., de Vries E., Ford R., Gwyther S., Mandrekar S., Shankar L., Bogaerts J., Chen A., Dancey J., Hayes W., Hodi F.S., Hoekstra O.S., Huang E.P., Lin N., Liu Y., Therasse P., Wolchok J.D., Seymour L. RECIST 1.1-Update and clarification: From the RECIST committee. Eur J Cancer. 2016; 62: 132–37. doi: 10.1016/j.ejca.2016.03.081.
21. Barraclough L.H., Swindell R., Livsey J.E., Hunter R.D., Davidson S.E. External beam boost for cancer of the cervix uteri when intracavitary therapy cannot be performed. Int J Radiat Oncol Biol Phys. 2008; 71(3): 772–78. doi: 10.1016/j.ijrobp.2007.10.066.
22. Park H.C., Shimizu S., Yonesaka A., Tsuchiya K., Ebina Y., Taguchi H., Katoh N., Kinoshita R., Ishikawa M., Sakuragi N., Shirato H. High dose three-dimensional conformal boost using the real-time tumor tracking radiotherapy system in cervical cancer patients unable to receive intracavitary brachytherapy. Yonsei Med J. 2010; 51(1): 93–99. doi: 10.3349/ymj.2010.51.1.93.
23. Kagei K., Tokuuye K., Okumura T., Ohara K., Shioyama Y., Sugahara S., Akine Y. Long-term results of proton beam therapy for carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 2003; 55(5): 1265–71. doi: 10.1016/s0360-3016(02)04075-0.
24. Cengiz M., Dogan A., Ozyigit G., Erturk E., Yildiz F., Selek U., Ulger S., Colak F., Zorlu F. Comparison of intracavitary brachytherapy and stereotactic body radiotherapy dose distribution for cervical cancer. Brachytherapy. 2012; 11(2): 125–29. doi: 10.1016/j.brachy.2011.12.001.
25. Georg D., Kirisits C., Hillbrand M., Dimopoulos J., Pötter R. Image-guided radiotherapy for cervix cancer: high-tech external beam therapy versus high-tech brachytherapy. Int J Radiat Oncol Biol Phys. 2008; 71(4): 1272–78. doi: 10.1016/j.ijrobp.2008.03.032.
26. Haas J.A., Witten M.R., Clancey O., Episcopia K., Accordino D., Chalas E. CyberKnife Boost for Patients with Cervical Cancer Unable to Undergo Brachytherapy. Front Oncol. 2012; 2: 25. doi: 10.3389/fonc.2012.00025.
27. Kubicek G.J., Xue J., Xu Q., Asbell S.O., Hughes L., Kramer N., Youssef A., Chen Y., Aikens J., Saul H., Pahlajani N., LaCouture T. Stereotactic body radiotherapy as an alternative to brachytherapy in gynecologic cancer. Biomed Res Int. 2013. doi: 10.1155/2013/898953.
28. Pedicini P., Strigari L., Caivano R., Fiorentino A., Califano G., Nappi A., Improta G., Storto G., Cozzolino M., Chiumento C., Fusco V., Vavassori A., Benassi M., Orecchia R., Salvatore M. Local tumor control probability to evaluate an applicator-guided volumetric-modulated arc therapy solution as alternative of 3D brachytherapy for the treatment of the vaginal vault in patients affected by gynecological cancer. J Appl Clin Med Phys. 2013; 14(2): 4075. doi: 10.1120/jacmp.v14i2.4075.
29. Albuquerque K., Tumati V., Lea J., Ahn C., Richardson D., Miller D., Timmerman R. A Phase II Trial of Stereotactic Ablative Radiation Therapy as a Boost for Locally Advanced Cervical Cancer. Int J Radiat Oncol Biol Phys. 2020; 106(3): 464–71. doi: 10.1016/j.ijrobp.2019.10.042.
30. Delgado D., Figueiredo A., Mendonça V., Jorge M., Abdulrehman M., de Pina M.F. Results from chemoradiotherapy for squamous cell cervical cancer with or without intracavitary brachytherapy. J Contemp Brachytherapy. 2019; 11(5): 417–22. doi: 10.5114/jcb.2019.88116.
31. Ito K., Shimizuguchi T., Karasawa K. Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy. Jpn J Clin Oncol. 2019; 49(3): 270–75. doi: 10.1093/jjco/hyy187.
32. Lazzari R., Riva G., Augugliaro M., Vavassori A., Dicuonzo S., Cattani F., Comi S., Colombo N., Jereczek-Fossa B.A. Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy. Int J Gynecol Cancer. 2020; 30(5): 607–12. doi: 10.1136/ijgc-2019-000735.
33. Mazzola R., Ricchetti F., Fiorentino A., Levra N.G., Fersino S., Di Paola G., Ruggieri R., Alongi F. Weekly Cisplatin and VolumetricModulated Arc Therapy With Simultaneous Integrated Boost for Radical Treatment of Advanced Cervical Cancer in Elderly Patients: Feasibility and Clinical Preliminary Results. Technol Cancer Res Treat. 2017; 16(3): 310–15. doi: 10.1177/1533034616655055
Review
For citations:
Startseva Zh.A., Lushnikova P.A., Sukhikh E.S. External beam radiation therapy as an alternative to brachytherapy for locally advanced cervical cancer. Siberian journal of oncology. 2025;24(2):162-168. (In Russ.) https://doi.org/10.21294/1814-4861-2025-24-2-162-168
Views:
508
Email this article 
